Shorter Infliximab Infusions Safe Without Routine Premeds

M Lane, A Almaiman, S Obasi, et al. J Pediatr Gastroenterol Nutr. 2026; Shorter infliximab infusion times without premedication do not increase adverse reactions.

Methods: This retrospective comparative cohort study analysed data from 1083 IFX infusions (369 patients) at a single center. One cohort received routine dual hydrocortisone/chlorphenamine premedication with longer infusion times (2.5 h induction/90 min maintenance; Group A, n=127), with a subsequent cohort without universal premedication and shorter infusions (2 h induction/60 min maintenance; Group B, n=242). There were 346 infusions in Group A (Jan 2019–June 2019) and 737 infusions in Group B (Jan 2023–June 2023). Patients in Group B received premedication if there had been even minor previous reactions, but not severe enough to necessitate termination of IFX.

Key findings:

  • Shorter infusions and omitting routine premedication did not increase acute infusion reaction rates: There were 13 infusion reactions in 12 patients in total (1.2/100 infusions); there were 5 reactions in 4 (3%) patients in Group A (1.5/100 infusions) and 8 reactions in 8 (3%) patients in Group B
  • Significantly more infusion reactions occurred during induction than maintenance therapy in both groups (3.4 vs. 0.7 reactions per 100 infusions respectively, p = 0.001, OR 5.08)
  • Universal premedication neither reduced early anti-IFX antibody positivity by first maintenance dose (n = 51; 33% vs. 17%, p = 0.23) nor overall antibody prevalence (31% vs. 37%, p = 0.164)
  • The most common dose used was 10 mg/kg (72% of patients); the most common dosing interval was every 6 weeks (41% of patients)
  • Administering dual premedication added at least 45 min to the day case stay at our institute

Discussion Point:

  • “Long post-infusion observation periods were originally routine practice at our facility, and others, but have been shortened in recent years. Across each study group, no reactions commenced after cessation of infusion. Our findings are in keeping with those of recent studies which also found that observations periods post-infusion did not augment patient safety.10“
  • Limitations include retrospective design with “non-standardised recording of infusion reactions or side effects”

My take: Most patients do not need premedications and can receive shorter infusions after induction dosing. In addition, reactions in this cohort occured during infusion; thus, observation afterwards did not enhance patient safety.

Related blog posts:

View from Airplane – Atlanta to Ft Lauderdale

Disclaimer: This blog, gutsandgrowth, assumes no responsibility for any use or operation of any method, product, instruction, concept or idea contained in the material herein or for any injury or damage to persons or property (whether products liability, negligence or otherwise) resulting from such use or operation. These blog posts are for educational purposes only. Specific dosing of medications (along with potential adverse effects) should be confirmed by prescribing physician.  Because of rapid advances in the medical sciences, the gutsandgrowth blog cautions that independent verification should be made of diagnosis and drug dosages. The reader is solely responsible for the conduct of any suggested test or procedure.  This content is not a substitute for medical advice, diagnosis or treatment provided by a qualified healthcare provider. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a condition.